INS and type 1 diabetes mellitus: Preliminary clinical evidence in this direction has already been provided by the prospective study conducted by Navodnik et al. [110], who showed that semaglutide (as add-on treatment to insulin) positively impacted endothelial function in patients with long-standing T1D.